22. In regulation 13—U.K.
(a)for paragraph (1) substitute—
“(1) In this regulation, “essential use active substance” means an active substance in respect of which the Secretary of State or a Devolved Authority has granted a derogation for essential use under [F1Article 22 of the Review Regulation].”;
(b)in paragraph (5)(c), for “Commission” substitute “ Secretary of State or Devolved Authority ”;
(c)in paragraph (6), for “Commission makes a decision or adopts a regulation” substitute “ Secretary of State or Devolved Authority issues a decision ”.
Textual Amendments
F1Words in Sch. 1 para. 22(a) substituted (31.12.2020 immediately before IP completion day) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 1 para. 16
Commencement Information
I1Sch. 1 para. 22 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)